title: Human neutrophil elastase releases two pools of mucinlike glycoconjugate from tracheal submucosal gland cells.
abstract: Neutrophil elastase can contribute to the pathogenesis of increased airway reactivity and excess mucus secretion in many pulmonary diseases. Ten nanomolar human neutrophil elastase (HNE) effectively empties airway serous cells, raising the question of why HNE is not equally effective at emptying mucous cells of their stored mucin because total release of mucin granules is not seen in postmortem examination of even the most severe disease. To better resolve the mucus secretagogue action of HNE, we measured secretion of mucinlike glycoconjugates (MGCs) released from freshly isolated swine tracheal submucosal gland cells in fractions of the superfusate acquired every 2 min. Six to fifty nanomolar HNE released a fixed quantity of MGCs at an increasing rate with increasing concentrations of enzyme, an action consistent with the release of cell surface mucinlike molecules. The polycation poly-L-lysine (1 microg/ml) released a similar transient of MGCs. A steady-state doubling of MGC rate of release was seen as long as 100 nM HNE was present, but this stimulus represented less than a 1% release of stored MGCs/min and was consistent with release of mucin vesicles from cell stores. Both actions of HNE were inhibited by the specific inhibitors L-680833 and DMP-777 but not by 30 microM erythromycin. Therefore, HNE release of MGCs from tracheal submucosal glands is limited by both the fixed quantity of the MGCs in the transient pool and by the small steady-state response to the higher concentrations of enzyme.
authors.affiliation: Department of Physiology and Biophysics, University of Mississippi Medical Center, Jackson, Mississippi 39216-4505, USA. twdyer@physiology.umsmed.edu
authors.forename: T M
authors.initials: TM
authors.lastname: Dwyer
authors.forename: J M
authors.initials: JM
authors.lastname: Farley
mesh_terms: D000818:Animals; D001384:Azetidines / Q000494:pharmacology; D006001:Glycoconjugates / Q000378:metabolism*; D006706:Homeostasis; D006801:Humans; D066298:In Vitro Techniques; D007769:Lactams / Q000494:pharmacology; D019272:Leukocyte Elastase / Q000494:pharmacology*; D008297:Male; D009077:Mucins / Q000378:metabolism*; D010648:Phenylacetates / Q000494:pharmacology; D010879:Piperazines / Q000494:pharmacology; D011107:Polylysine / Q000494:pharmacology; D020545:Respiratory Mucosa / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D015842:Serine Proteinase Inhibitors / Q000494:pharmacology; D013552:Swine; D014132:Trachea / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*
chemical_list: D001384:Azetidines; D006001:Glycoconjugates; D007769:Lactams; D009077:Mucins; D010648:Phenylacetates; D010879:Piperazines; D015842:Serine Proteinase Inhibitors; C083284:L 680833; D011107:Polylysine; C105999:DMP 777; D019272:Leukocyte Elastase